Compounds > 3-methylpseudouridine

Page last updated: 2024-08-02 18:42:41

3-methylpseudouridine

Description

3-methylpseudouridine: structure given in first source [MeSH]

3-Methylpseudouridine : no description available [CHeBI]

Cross-References

ID Source	ID
PubMed CID	11207624
SCHEMBL ID	1964384
CHEBI ID	178091
MeSH ID	M0106740

Synonyms (11)

Synonym
CHEBI:178091
5-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3-methyl-1h-pyrimidine-2,4-dione
81691-06-7
3-methylpseudouridine
2,4(1h,3h)-pyrimidinedione, 3-methyl-5-beta-d-ribofuranosyl-
nsc 363818
SCHEMBL1964384
5-((2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3-methylpyrimidine-2,4(1h,3h)-dione
A51130
5-((2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-3-methylpyrimidine-2,4(1h,3h)-dione
A848827

Drug Classes (2)

Class	Description
carbohydrate derivative	Any organooxygen compound derived from a carbohydrate by replacement of one or more hydroxy group(s) by an amino group, a thiol group or similar heteroatomic groups. The term also includes derivatives of these compounds.
nucleobase-containing molecular entity	Any compound that has a nucleobase as a part.

Research

Studies (6)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	3 (50.00)	18.7374
1990's	1 (16.67)	18.2507
2000's	2 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	6 (100.00%)	84.16%

Substance	Studies	Classes	Roles	First Year	Last Year	Average Age	Relationship Strength	Trials	pre-1990	1990's	2000's	2010's	post-2020
1,n(2)-propanodeoxyguanosine	0	carbohydrate derivative; nucleobase-containing molecular entity		0	0		low	0	0	0	0	0	0
wyosine	0	carbohydrate derivative; nucleobase-containing molecular entity		0	0		low	0	0	0	0	0	0
troxacitabine	0	carbohydrate derivative; nucleobase-containing molecular entity		0	0		low	0	0	0	0	0	0
2-(4-amino-5-iodo-7-pyrrolo[2,3-d]pyrimidinyl)-5-(hydroxymethyl)oxolane-3,4-diol	0	nucleobase-containing molecular entity		0	0		low	0	0	0	0	0	0
cytidylyl-(3'-5')-cytidine	0	nucleobase-containing molecular entity		0	0		low	0	0	0	0	0	0
uridine monophosphate-uridine	0	nucleobase-containing molecular entity		0	0		low	0	0	0	0	0	0
taribavirin	0	nucleobase-containing molecular entity		0	0		low	0	0	0	0	0	0

Substance	Studies	Classes	Roles	First Year	Last Year	Average Age	Relationship Strength	Trials	pre-1990	1990's	2000's	2010's	post-2020
uracil	1	pyrimidine nucleobase; pyrimidone	allergen; Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; prodrug; Saccharomyces cerevisiae metabolite	1989	1989	35.0	low	0	1	0	0	0	0
hydralazine	1	azaarene; hydrazines; ortho-fused heteroarene; phthalazines	antihypertensive agent; vasodilator agent	1974	1974	50.0	low	0	1	0	0	0	0
uridine	4	uridines	drug metabolite; fundamental metabolite; human metabolite	1974	2005	36.5	high	0	3	0	1	0	0
methionine	2	aspartate family amino acid; L-alpha-amino acid; methionine zwitterion; methionine; proteinogenic amino acid	antidote to paracetamol poisoning; human metabolite; micronutrient; mouse metabolite; nutraceutical	1974	1989	42.5	medium	0	2	0	0	0	0
pseudouridine	6	pseudouridines	fundamental metabolite	1974	2005	32.2	high	0	3	1	2	0	0
1-methylpseudouridine	1	methylpseudouridine		1974	1974	50.0	medium	0	1	0	0	0	0
3-methyluridine	1			2005	2005	19.0	medium	0	0	0	1	0	0
efrotomycin	1			1989	1989	35.0	medium	0	1	0	0	0	0

Condition	Indicated	Studies	First Year	Last Year	Average Age	Relationship Strength	Trials	pre-1990	1990's	2000's	2010's	post-2020